1. Home
  2. RNW vs EVO Comparison

RNW vs EVO Comparison

Compare RNW & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$5.28

Market Cap

1.9B

Sector

Utilities

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.47

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
EVO
Founded
2011
1993
Country
United Kingdom
Germany
Employees
4336
4766
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
821.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNW
EVO
Price
$5.28
$2.47
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$7.00
AVG Volume (30 Days)
620.6K
110.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.97
$7.13
P/E Ratio
$14.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.05
$2.31
52 Week High
$8.24
$4.80

Technical Indicators

Market Signals
Indicator
RNW
EVO
Relative Strength Index (RSI) 42.86 30.14
Support Level $5.27 N/A
Resistance Level $5.58 $3.78
Average True Range (ATR) 0.12 0.10
MACD -0.01 -0.08
Stochastic Oscillator 32.40 13.89

Price Performance

Historical Comparison
RNW
EVO

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: